|
[1]
|
Bade, B.C. and Dela Cruz, C.S. (2020) Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clinics in Chest Medicine, 41, 1-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Miller, K.D., Nogueira, L., Devasia, T., et al. (2022) Cancer Treatment and Survivorship Statistics, 2022. CA: A Cancer Journal for Clinicians, 72, 409-436. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Hirsch, F.R., Scagliotti, G.V., Mulshine, J.L., et al. (2017) Lung Cancer: Current Therapies and New Targeted Treatments. The Lancet, 389, 299-311. [Google Scholar] [CrossRef]
|
|
[5]
|
Reck, M. and Rabe, K.F. (2017) Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer. The New England Journal of Medicine, 377, 849-861. [Google Scholar] [CrossRef]
|
|
[6]
|
Wang, M., Herbst, R.S. and Boshoff, C. (2021) Toward Personal-ized Treatment Approaches for Non-Small-Cell Lung Cancer. Nature Medicine, 27, 1345-1356. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Nasim, F., Sabath, B.F. and Eapen, G.A. (2019) Lung Cancer. The Medical Clinics of North America, 103, 463-473. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Su, M., Ouyang, X. and Song, Y. (2022) Neutrophil to Lympho-cyte Ratio, Platelet to Lymphocyte Ratio, and Monocyte to Lymphocyte Ratio in Depression: A Meta-Analysis. Journal of Affective Disorders, 308, 375-383. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Gu, X.B., Tian, T., Tian, X.J., et al. (2015) Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer: A Meta-Analysis. Scientific Reports, 5, Article No. 12493. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
张羿, 朱正秋, 薛静. 外周血中性粒细胞与淋巴细胞比值预测晚期非小细胞肺癌免疫治疗疗效的价值[J]. 现代肿瘤医学, 2022, 30(1): 54-57.
|
|
[11]
|
Templeton, A.J., Mcnamara, M.G., Šeruga, B., et al. (2014) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Re-view and Meta-Analysis. Journal of the National Cancer Institute, 106, dju124. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Halazun, K.J., Aldoori, A., Malik, H.Z., et al. (2008) Elevated Preoperative Neutrophil to Lymphocyte Ratio Predicts Survival Following Hepatic Resection for Colorectal Liver Metastases. Euro-pean Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Associa-tion of Surgical Oncology, 34, 55-60. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Cedrés, S., Torrejon, D., Martínez, A., et al. (2012) Neutrophil to Lymphocyte Ratio (NLR) as an Indicator of Poor Prognosis in Stage IV Non-Small Cell Lung Cancer. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 14, 864-869. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
朱振成, 罗昆仑, 谢伟选, 祝梦娇, 朱庆洲, 柏杨, 李福利, 刘伟伟. 术前/术后中性粒细胞-淋巴细胞比值与格拉斯哥预后评分对胆囊癌预后的预测价值[J]. 中国普通外科杂志, 2020, 29(8): 11.
|
|
[15]
|
Yan, S., Zhang, P., Xu, W., et al. (2015) Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis. Mediators of Inflammation, 2015, Article ID: 764250. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Fini, M.A., Elias, A., Johnson, R.J., et al. (2012) Contribution of Uric Acid to Cancer Risk, Recurrence, and Mortality. Clinical and Translational Medicine, 1, 16. [Google Scholar] [CrossRef] [PubMed]
|